# Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

> **NCT00032370** · NA · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 510 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **PROCEDURE:** Vascular surgery with best medical treatment
- **PROCEDURE:** Coronary artery bypass grafting (CABG)
- **PROCEDURE:** Percutaneous transluminal coronary angioplasty (PTCA)

## Key facts

- **NCT ID:** NCT00032370
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-08
- **Primary completion:** 2004-02
- **Final completion:** 2004-05
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2015-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032370, "Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00032370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*